No Observed Adverse Effect Level (NOAEL)

The No Observed Adverse Effect Level (NOAEL) is a fundamental concept in toxicology and cosmetic safety assessment. It represents the highest tested dose of a substance at which no statistically or biologically significant increase in the frequency or severity of adverse effects is observed compared to the control group.

The NOAEL is typically derived from repeated-dose toxicity studies (28-day, 90-day, or chronic studies) conducted in laboratory animals, although human data are preferred when available. The most relevant NOAEL for cosmetic safety assessment is usually from the oral repeated-dose study, unless dermal data are available and more appropriate for the specific product type.

In the Margin of Safety calculation (MoS = NOAEL / SED), the NOAEL serves as the numerator, representing the "safe" reference dose. The NOAEL is expressed in mg/kg body weight/day for systemic exposure assessments. A higher NOAEL indicates the substance is less toxic (adverse effects only occur at higher doses), resulting in a higher MoS and greater confidence in safety.

When a NOAEL cannot be determined (e.g., effects are observed even at the lowest dose tested), the LOAEL (Lowest Observed Adverse Effect Level) may be used with an additional uncertainty factor. The benchmark dose (BMD) approach is increasingly preferred as a more sophisticated alternative to the NOAEL approach, as it uses the complete dose-response data rather than a single dose point.